NIOX Group PLC (NIOX) - Net Assets

Latest as of December 2025: GBX67.60 Million GBX ≈ $8.22K USD

Based on the latest financial reports, NIOX Group PLC (NIOX) has net assets worth GBX67.60 Million GBX (≈ $8.22K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX76.20 Million ≈ $9.27K USD) and total liabilities (GBX8.60 Million ≈ $1.05K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of NIOX Group PLC to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX67.60 Million
% of Total Assets 88.71%
Annual Growth Rate 6.99%
5-Year Change -17.46%
10-Year Change 2.27%
Growth Volatility 114.11

NIOX Group PLC - Net Assets Trend (2013–2025)

This chart illustrates how NIOX Group PLC's net assets have evolved over time, based on quarterly financial data. Also explore NIOX Group PLC assets under control for the complete picture of this company's asset base.

Annual Net Assets for NIOX Group PLC (2013–2025)

The table below shows the annual net assets of NIOX Group PLC from 2013 to 2025. For live valuation and market cap data, see NIOX market cap overview.

Year Net Assets Change
2025-12-31 GBX67.60 Million
≈ $8.22K		 +13.61%
2024-12-31 GBX59.50 Million
≈ $7.24K		 -29.00%
2023-12-31 GBX83.80 Million
≈ $10.20K		 0.00%
2023-12-30 GBX83.80 Million
≈ $10.20K		 +2.32%
2022-12-31 GBX81.90 Million
≈ $9.96K		 0.00%
2022-12-30 GBX81.90 Million
≈ $9.96K		 +22.60%
2021-12-31 GBX66.80 Million
≈ $8.13K		 0.00%
2021-12-30 GBX66.80 Million
≈ $8.13K		 +1.06%
2020-12-31 GBX66.10 Million
≈ $8.04K		 0.00%
2020-12-30 GBX66.10 Million
≈ $8.04K		 -22.05%
2019-12-31 GBX84.80 Million
≈ $10.32K		 0.00%
2019-12-30 GBX84.80 Million
≈ $10.32K		 -53.66%
2018-12-31 GBX183.00 Million
≈ $22.27K		 0.00%
2018-12-30 GBX183.00 Million
≈ $22.27K		 -50.75%
2017-12-31 GBX371.60 Million
≈ $45.21K		 0.00%
2017-12-30 GBX371.60 Million
≈ $45.21K		 +18.87%
2016-12-31 GBX312.60 Million
≈ $38.03K		 0.00%
2016-12-30 GBX312.60 Million
≈ $38.03K		 -29.10%
2015-12-31 GBX440.90 Million
≈ $53.64K		 0.00%
2015-12-30 GBX440.90 Million
≈ $53.64K		 +131.08%
2014-12-31 GBX190.80 Million
≈ $23.21K		 0.00%
2014-12-30 GBX190.80 Million
≈ $23.21K		 +535.05%
2013-12-31 GBX30.05 Million
≈ $3.66K		 0.00%
2013-12-30 GBX30.05 Million
≈ $3.66K		 --

Equity Component Analysis

This analysis shows how different components contribute to NIOX Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 11887900000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings GBX45.40 Million 61.60%
Common Stock GBX300.00K 0.41%
Other Comprehensive Income GBX27.70 Million 37.58%
Other Components GBX300.00K 0.41%
Total Equity GBX73.70 Million 100.00%

NIOX Group PLC Competitors by Market Cap

The table below lists competitors of NIOX Group PLC ranked by their market capitalization.

Company Market Cap
Poddar Housing and Development Limited
NSE:PODDARHOUS
 $3.41 Million
Hochdorf Holding AG
SW:HOCN
 $3.41 Million
FIRST CLASS MET. LS-001
F:WN9
 $3.42 Million
Libas Consumer Products Limited
NSE:LIBAS
 $3.42 Million
NuGen Medical Devices Inc
V:NGMD
 $3.41 Million
Electromagnetic Geoservices ASA
OL:EMGS
 $3.40 Million
Superior Mining International Corp
V:SUI
 $3.40 Million
Ordissimo
PA:ALORD
 $3.40 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in NIOX Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 59,500,000 to 73,700,000, a change of 14,200,000 (23.9%).
  • Net income of 7,000,000 contributed positively to equity growth.
  • Dividend payments of 5,000,000 reduced retained earnings.
  • New share issuances of 100,000 increased equity.
  • Other comprehensive income increased equity by 12,100,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX7.00 Million +9.5%
Dividends Paid GBX5.00 Million -6.78%
Share Issuances GBX100.00K +0.14%
Other Comprehensive Income GBX12.10 Million +16.42%
Total Change GBX- 23.87%

Book Value vs Market Value Analysis

This analysis compares NIOX Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 387.47x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 417.95x to 387.47x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-30 GBX0.16 GBX67.00 x
2013-12-31 GBX0.16 GBX67.00 x
2014-12-30 GBX1.13 GBX67.00 x
2014-12-31 GBX1.13 GBX67.00 x
2015-12-30 GBX1.64 GBX67.00 x
2015-12-31 GBX1.64 GBX67.00 x
2016-12-30 GBX0.99 GBX67.00 x
2016-12-31 GBX0.99 GBX67.00 x
2017-12-30 GBX0.70 GBX67.00 x
2017-12-31 GBX0.70 GBX67.00 x
2018-12-30 GBX0.37 GBX67.00 x
2018-12-31 GBX0.37 GBX67.00 x
2019-12-30 GBX0.23 GBX67.00 x
2019-12-31 GBX0.23 GBX67.00 x
2020-12-30 GBX0.17 GBX67.00 x
2020-12-31 GBX0.17 GBX67.00 x
2021-12-30 GBX0.15 GBX67.00 x
2021-12-31 GBX0.15 GBX67.00 x
2022-12-30 GBX0.18 GBX67.00 x
2022-12-31 GBX0.18 GBX67.00 x
2023-12-30 GBX0.19 GBX67.00 x
2023-12-31 GBX0.19 GBX67.00 x
2024-12-31 GBX0.13 GBX67.00 x
2025-12-31 GBX0.17 GBX67.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently NIOX Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.50%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 14.37%
  • • Asset Turnover: 0.64x
  • • Equity Multiplier: 1.03x
  • Recent ROE (9.50%) is above the historical average (-28.76%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -66.50% 0.00% 0.00x 1.27x GBX-22.99 Million
2013 -66.50% 0.00% 0.00x 1.27x GBX-22.99 Million
2014 -18.40% 0.00% 0.00x 1.05x GBX-54.18 Million
2014 -18.40% 0.00% 0.00x 1.05x GBX-54.18 Million
2015 -12.22% -462.04% 0.02x 1.20x GBX-90.75 Million
2015 -12.22% -462.04% 0.02x 1.20x GBX-90.75 Million
2016 -48.91% -594.37% 0.07x 1.19x GBX-165.37 Million
2016 -48.91% -594.37% 0.07x 1.19x GBX-165.37 Million
2017 -44.08% -214.04% 0.12x 1.79x GBX-121.58 Million
2017 -44.08% -214.04% 0.12x 1.79x GBX-121.58 Million
2018 -93.01% -242.44% 0.16x 2.44x GBX-129.69 Million
2018 -93.01% -242.44% 0.16x 2.44x GBX-129.69 Million
2019 -56.96% -139.60% 0.14x 2.91x GBX-56.78 Million
2019 -56.96% -139.60% 0.14x 2.91x GBX-56.78 Million
2020 -50.68% -140.17% 0.23x 1.56x GBX-40.11 Million
2020 -50.68% -140.17% 0.23x 1.56x GBX-40.11 Million
2021 5.39% 12.90% 0.32x 1.29x GBX-3.08 Million
2021 5.39% 12.90% 0.32x 1.29x GBX-3.08 Million
2022 19.66% 51.44% 0.32x 1.20x GBX7.91 Million
2022 19.66% 51.44% 0.32x 1.20x GBX7.91 Million
2023 12.77% 29.08% 0.40x 1.09x GBX2.32 Million
2023 12.77% 29.08% 0.40x 1.09x GBX2.32 Million
2024 6.22% 8.85% 0.61x 1.15x GBX-2.25 Million
2025 9.50% 14.37% 0.64x 1.03x GBX-370.00K

Industry Comparison

This section compares NIOX Group PLC's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $37,269,869
  • Average return on equity (ROE) among peers: -23.90%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
NIOX Group PLC (NIOX) GBX67.60 Million -66.50% 0.13x $3.41 Million
AOTI Inc (AOTI) $3.41 Million 51.02% 1.74x $891.93K
Creo Medical Group PLC (CREO) $1.37 Million -123.43% 0.18x $633.60K
EKF Diagnostics Holdings Plc (EKF) $-3.03 Million 0.00% 0.00x $1.39 Million
Inspiration Healthcare Group PLC (IHC) $1.65 Million 0.00% 0.38x $322.92K
Polarean Imaging Plc (POLX) $8.73 Million -75.05% 0.25x $11.75K
Rua Life Sciences PLC (RUA) $8.51 Million -17.06% 0.19x $147.24K
Smith & Nephew PLC (SN) $273.58 Million 25.01% 1.35x $118.48 Million
Surgical Innovations Group plc (SUN) $3.93 Million -51.73% 0.98x $51.07K

About NIOX Group PLC

LSE:NIOX UK Medical Devices
Market Cap
$3.41 Million
GBX28.01 Billion GBX
Market Cap Rank
#29019 Global
#552 in UK
Share Price
GBX67.00
Change (1 day)
-1.47%
52-Week Range
GBX54.40 - GBX76.00
All Time High
GBX306.79
Categories
Companies in UK Medical Devices
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more